A share price of Cg Oncology Inc [CGON] is currently trading at $53.72, down -0.89%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 34.17% over the last week, with a monthly amount glided 28.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on December 11, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $70. On October 08, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $90 on the stock. Piper Sandler started tracking the stock assigning an Overweight rating and suggested a price target of $55 on August 19, 2025. JP Morgan started tracking with an Overweight rating for this stock on May 02, 2025, and assigned it a price target of $41. In a note dated April 16, 2025, Scotiabank initiated an Sector Perform rating and provided a target price of $23 on this stock.
Cg Oncology Inc experienced fluctuations in its stock price throughout the past year between $14.80 and $57.40. Currently, Wall Street analysts expect the stock to reach $73.86 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $53.72 at the most recent close of the market. An investor can expect a potential return of 37.49% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Trailing Twelve Months sales for Cg Oncology Inc [NASDAQ:CGON] were 2.17M which represents 3774.42% growth. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -82.85%, Pretax Profit Margin comes in at -69.68%, and Net Profit Margin reading is -69.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.22 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 22.79. Further, the Quick Ratio stands at 22.74, while the Cash Ratio is 1.48. Considering the valuation of this stock, the price to sales ratio is 1996.95, the price to book ratio is 6.12.
Transactions by insiders
Recent insider trading involved JAMES MULAY, Director, that happened on Jan 09 ’26 when 13109.0 shares were purchased. Director, POST LEONARD E completed a deal on Nov 17 ’25 to sell 1000.0 shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on Oct 13 ’25.
